About the Authors
- Bas Cornelis Jansen
-
Roles Conceptualization, Software, Validation, Writing – original draft, Writing – review & editing
* E-mail: bas.jansen@ludger.com
Affiliation Research & Development, Ludger Limited., Abingdon, Oxfordshire, United Kingdom
- Lise Hafkenscheid
-
Roles Validation, Writing – original draft
Affiliation Department of Rheumatology, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands
- Albert Bondt
-
Roles Supervision, Validation, Writing – original draft, Writing – review & editing
Affiliations Department of Rheumatology, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands, Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands
- Richard Andrew Gardner
-
Roles Validation, Writing – original draft, Writing – review & editing
Affiliation Research & Development, Ludger Limited., Abingdon, Oxfordshire, United Kingdom
- Jenifer Lynn Hendel
-
Roles Validation, Writing – original draft
Affiliation Research & Development, Ludger Limited., Abingdon, Oxfordshire, United Kingdom
- Manfred Wuhrer
-
Roles Supervision, Writing – original draft, Writing – review & editing
Affiliation Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands
- Daniel Ian Richard Spencer
-
Roles Supervision, Writing – original draft, Writing – review & editing
Affiliation Research & Development, Ludger Limited., Abingdon, Oxfordshire, United Kingdom
Competing Interests
The authors have declared that no competing interests exist. The software published in this article has been partially developed at Ludger. However, the software is released completely open source which is why the authors have declared no competing interests. BCJ, RAG, JLH and DIRS work for Ludger Ltd – a commercial company that specialises in the development and validation of glycoprofiling technology for biologic therapeutics and biological tissues. Some of the Ludger products include glycan purification kits and glycan release kits. There are no patents and products in development. This does not alter the authors’ adherence to PLOS ONE policies on sharing data and materials.